Pregnancy Related Clinical Trial
Official title:
Improving Access to Abortion in the Republic of Georgia
NCT number | NCT04458558 |
Other study ID # | 2.1 |
Secondary ID | |
Status | Recruiting |
Phase | Phase 4 |
First received | |
Last updated | |
Start date | June 30, 2020 |
Est. completion date | April 1, 2021 |
In the Republic of Georgia, the medical abortion regimen involves three in-person visits. This study aims to pilot and evaluate a simplified medical abortion service delivery model that will reduce the number of in-person visits to only one visit for diagnosis and counseling. Medication will be mailed along with two multi-level pregnancy tests to study participants, who will assess their abortion outcome at home.
Status | Recruiting |
Enrollment | 120 |
Est. completion date | April 1, 2021 |
Est. primary completion date | April 1, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 16 Years and older |
Eligibility |
Inclusion Criteria: - Women seeking medical abortion through 58 days gestation - Eligible for medical abortion according to study provider's assessment - Able to receive physical mail - Have access to a phone - Be willing and able to consent to participate in the study - Be willing to follow study procedures Exclusion Criteria: - Not seeking medical abortion - Contraindications to medical abortion |
Country | Name | City | State |
---|---|---|---|
Georgia | Batumi Medical Center | Batumi | |
Georgia | David Gagua Clinic | Tbilisi | |
Georgia | Clinic Elite | Zestap'oni |
Lead Sponsor | Collaborator |
---|---|
Center for Information and Counseling on Reproductive Health - Tanadgoma | Grand Challenges Canada, Gynuity Health Projects, Healthy Life |
Georgia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of participants who report satisfactory experience | Number of participants who report being "satisfied" or "very satisfied" with the simplified medical abortion service delivery model | Day 14 following initial medical abortion visit | |
Primary | Number of providers who report satisfactory experience | Number of providers who report being "satisfied" or "very satisfied" with the simplified medical abortion service delivery model | End of the study, month 15 | |
Secondary | Number of participants with adverse event | Number of participants who had a medical problem that required them to go to the hospital, emergency department or a doctor's office (other than regularly scheduled follow-up visit) since receiving medical abortion pills | Up to 6 weeks after initial medical abortion visit | |
Secondary | Number of participants with a complete abortion with medication alone and who do not require additional interventions to complete the procedure | Number of participants who report that their abortion is complete as assessed by the multi-level pregnancy test and medical history. | Up to 6 weeks after initial medical abortion visit | |
Secondary | Number of particpants with adverse event associated with mailing of medical abortion medications | Number of participants who had a problem (such as delayed and lost packages) receiving medical abortion medications by mail | Up to 6 weeks after initial medical abortion visit | |
Secondary | Cost associated with the simplified medical abortion service delivery model | Cost savings associated with participant travel to the clinic and cost of the standard care at the clinic. | Up to 6 weeks after initial medical abortion visit | |
Secondary | Number of participants who refuse to receive medical abortion pills by mail | Number of participants who refuse to receive medical abortion pills by mail during the study period | End of the study, month 15 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05017974 -
Research on Improving Sleep During Pregnancy
|
N/A | |
Completed |
NCT03284515 -
Vaccination In Pregnancy Gene Signature: VIP Signature Study
|
||
Recruiting |
NCT05969795 -
Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support
|
Phase 1 | |
Recruiting |
NCT06051201 -
Innovation for Small-scale Experiments: ReceptIVFity Test
|
N/A | |
Recruiting |
NCT04828382 -
Prospective Study of Pregnancy in Women With Cystic Fibrosis
|
||
Enrolling by invitation |
NCT04527926 -
STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy
|
N/A | |
Recruiting |
NCT04278651 -
Early Antenatal Support for Iron Deficiency Anemia
|
Phase 4 | |
Recruiting |
NCT04405700 -
Measuring Adverse Pregnancy and Newborn Congenital Outcomes
|
||
Recruiting |
NCT06258902 -
Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
|
||
Completed |
NCT05487196 -
Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia
|
Phase 2 | |
Completed |
NCT03750968 -
Lutein & Zeaxanthin in Pregnancy - Carotenoid Supplementation During Pregnancy: Ocular and Systemic Effects
|
Phase 2 | |
Enrolling by invitation |
NCT06127277 -
Next4You: A Fully Mobile Relationships Based Program for Youth in Foster Care
|
N/A | |
Completed |
NCT05897697 -
Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study
|
||
Recruiting |
NCT05899101 -
The Impact of Opioid and Cannabis Exposure on Fetal Growth
|
||
Completed |
NCT05502510 -
Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
|
||
Completed |
NCT04296396 -
Opioid Prescription After Cesarean Trial
|
Phase 3 | |
Not yet recruiting |
NCT06069856 -
Multiple Micronutrient Supplementation (MMS) IFA- Iron Dose Acceptability Crossover Trial
|
Phase 3 | |
Not yet recruiting |
NCT06069869 -
Multiple Micronutrient Supplementation (MMS) Iron Dose Acceptability Crossover Trial
|
Phase 3 | |
Not yet recruiting |
NCT06163651 -
Evaluating a One-Year Version of the Parent-Child Assistance Program
|
N/A | |
Not yet recruiting |
NCT06079918 -
Multiple Micronutrient Supplementation for Maternal Anemia Prevention in Tanzania
|
Phase 3 |